Author

G. L. Wyatt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

T. R. Lyons· 2 shared C. Young· 1 shared J. K. Richer· 1 shared L. Crump· 1 shared L. S. Crump· 1 shared R. Chapkin· 1 shared T. Gustafson· 1 shared T. R. Rutherford· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

T. R. Lyons

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivOct 5, 2020

Hormonal regulation of Semaphorin 7a in ER+ breast cancer drives therapeutic resistance

L. S. Crump, G. L. Wyatt, T. R. Rutherford…·T. R. Lyons

This study identifies SEMA7A as a driver of therapeutic resistance in ER+ breast cancer and suggests targeting survival signaling pathways as a potential treatment strategy.

DOI 10.1158/0008-5472.can-20-1601

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivMay 10, 2019

Cross-talk between SIM2s and NFkB regulates cyclooxygenase 2 expression in breast cancer

G. L. Wyatt, C. Young, L. Crump…·T. R. Lyons

This study shows that SIM2s inhibits NFkB activation and COX-2 expression in breast cancer, suggesting a potential therapeutic target.

DOI 10.1186/s13058-019-1224-y

humanexperimental assay

𝕏 PostBluesky